Latest News and Press Releases

Vectura Group plc 2017 Preliminary Results - Performance in-line with expectations, with strong in-market growth from key inhaled products - Chippenham, UK - 21 March 2018: Vectura Group...

This announcement contains inside information Vectura Group plc 2017 Pre-close Trading Update and Refocussed Investment Strategy Chippenham, UK - 4 January 2018: Vectura Group plc (LSE:...

Vectura Group plc New development and licence agreement for a US inhaled generic (VR2081) Chippenham, UK - 28 June 2017: Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an...

Vectura Group plc Launch of UtibronTM Neohaler® in the US Chippenham, UK - 3 April 2017: Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading device and...

Vectura Group plc Pre-close update Significant business development progress with year-end revenues in line with expectations Chippenham, UK - 11 January 2017: Vectura Group plc (LSE: VEC)...

Vectura Group plc (LSE:VEC) ("Vectura", "the Group"), an industry-leading inhaled airways disease focused business, reports that Novartis announced today that it has signed a licensing agreement with...